A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.

Also called NCT01742585

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 163 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01742585
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01742585. Randomized; quadruple masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
Condition
Renal Insufficiency
Condition
Hyperphosphatemia
Intervention (Drug)
ASP1585
Intervention (Drug)
placebo
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01742585
Content hash
a0744ddec1bc6bca723ccd21e3f9650a37e0b5ffb3acf32136c6735e8330bba6